Vitamin D and metabolic health with special reference to the effect of vitamin D on serum lipids

Progress in Lipid Research

Volumn 50, Issue 4, 2011, Pages 303-312

  Jorde, Rolf ^a,b   Grimnes, Guri ^a  

^a UNIVERSITY OF TROMSØ   (Norway)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Lipids; Metabolism; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; CALCIUM; CHOLESTEROL; COLECALCIFEROL; ERGOCALCIFEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; TRIACYLGLYCEROL; VITAMIN D;

BORDERLINE HYPERTENSION; CARDIOVASCULAR RISK; DOSE RESPONSE; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; HUMAN; ISCHEMIC HEART DISEASE; LIPID BLOOD LEVEL; METABOLIC DISORDER; METABOLISM; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; TRIACYLGLYCEROL BLOOD LEVEL; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION;

EID: 79959816051     PISSN: 01637827     EISSN: 18732194     Source Type: Journal    
DOI: 10.1016/j.plipres.2011.05.001     Document Type: Review

References (105)

1. H.F. DeLuca Overview of general physiologic features and functions of vitamin D Am J Clin Nutr 80 2004 1689S 1696S
2. N.M. Maalouf The noncalciotropic actions of vitamin D: recent clinical developments Curr Opin Nephrol Hypertens 17 2008 408 415
3. D.D. Bikle, E. Gee, B. Halloran, M.A. Kowalski, E. Ryzen, and J.G. Haddad Assessment of the free fraction of 25-hydroxyvitamin D in serum and its regulation by albumin and the vitamin D-binding protein J Clin Endocrinol Metab 63 1986 954 959 (Pubitemid 16004301)
4. M.F. Holick Vitamin D deficiency N Engl J Med 357 2007 266 281
5. J. Parker, O. Hashmi, D. Dutton, A. Mavrodaris, S. Stranges, and N.B. Kandala Levels of vitamin D and cardiometabolic disorders: systematic review and meta-analysis Maturitas 65 2010 225 236
6. P. Lips Worldwide status of vitamin D nutrition J Steroid Biochem Mol Biol 121 2010 297 300
7. M.S. Hutchinson, G. Grimnes, R. Joakimsen, Y. Figenschau, and R. Jorde Low serum 25- hydroxyvitamin D levels are associated with increased all-cause mortality risk in a general population: the Tromsø study Eur J Endocrinol 162 2010 935 942
8. S. Pilz, H. Dobnig, G. Nijpels, R.J. Heine, C.D. Stehouwer, and M.B. Snijder Vitamin D and mortality in older men Clin Endocrinol 71 2009 666 672
9. M.L. Melamed, E.D. Michos, W. Post, and B. Astor 25-hydroxyvitamin D levels and the risk of mortality in the general population Arch Intern Med 168 2008 1629 1637
10. A.A. Ginde, R. Scragg, R.S. Schwartz, and C.A. Camargo Jr Prospective study of serum 25-hydroxyvitamin D level, cardiovascular disease mortality and all-cause mortality in older US adults J Am Geriatr Soc 57 2009 1595 1603
11. K. Michaëlsson, J.A. Baron, G. Snellman, R. Gedeborg, L. Byberg, and J. Sundström Plasma vitamin D and mortality in older men: a community-based prospective cohort study Am J Clin Nutr 92 2010 841 848
12. K. Fiscella, and P. Franks Vitamin D Race, and cardiovascular mortality: findings from a national US sample Ann Fam Med 8 2010 11 18
13. P. Autier, and S. Gandini Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials Arch Intern Med 167 2007 1730 1737 (Pubitemid 47403059)
14. M. Chung, E.M. Balk, M. Brendel, S. Ip, J. Lau, and J. Lee Vitamin D and calcium: a systematic review of health outcomes Evid Rep Technol Assess 183 2009 1 420
15. P.M. Cawthon, N. Parimi, E. Barrett-Connor, G.A. Laughlin, K.E. Ensrud, and A.R. Hoffman Cummings SR; Osteoporotic Fractures in Men (MrOS) Research Group. Serum 25-hydroxyvitamin D, parathyroid hormone, and mortality in older men J Clin Endocrinol Metab 95 2010 4625 4634
16. S.K. Jassal, M. Chonchol, D. von Mühlen, G. Smits, and E. Barrett-Connor Vitamin d, parathyroid hormone, and cardiovascular mortality in older adults: the rancho bernardo study Am J Med 123 2010 1114 1120
17. E. Giovannucci, Y. Liu, B.W. Hollis, and E.B. Rimm 25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study Arch Intern Med 168 2008 1174 1180 (Pubitemid 351831400)
18. M.L. Melamed, P. Muntner, E.D. Michos, J. Uribarri, C. Weber, and J. Sharma Serum 25-Hydroxyvitamin D Levels and the prevalence of peripheral arterial disease. Results from NHANES 2001 to 2004 Arterioscler Thromb Vasc Biol 28 2008 1179 1185
19. S. Pilz, H. Dobnig, J.E. Fischer, B. Wellnitz, U. Seelhorst, and B.O. Boehm Low vitamin D levels predicts stroke in patients referred to coronary angiography Stroke 39 2008 2611 2613
20. T.J. Wang, M.J. Pencina, S.L. Booth, P.F. Jacques, E. Ingelsson, and K. Lanier Vitamin D deficiency and risk of cardiovascular disease Circulation 117 2008 503 511
21. L. Wang, J.E. Manson, Y. Song, and H.D. Sesso Systematic review: vitamin D and calcium supplementation in prevention of cardiovascular events Ann Intern Med 152 2010 315 323
22. A.G. Pittas, M. Chung, T. Trikalinos, J. Mitri, M. Brendel, and K. Patel Systematic review: vitamin D and cardiometabolic outcomes Ann Intern Med 152 2010 307 314
23. E. Kamycheva, R. Jorde, Y. Figenschau, and E. Haug Insulin sensitivity in subjects with secondary hyperparathyroidism and the effect of a low serum 25-hydroxyvitamin D level on insulin sensitivity J Endocrinol Invest 30 2007 126 132 (Pubitemid 46614443)
24. K.C. Chiu, A. Chu, V.L. Go, and M.F. Saad Hypovitaminosis D is associated with insulin resistance and β cell dysfunction Am J Clin Nutr 79 2004 820 825 (Pubitemid 41103882)
25. A.G. Need, P.D. O'Loughlin, M. Horowitz, and B.E. Nordin Relationship between fasting serum glucose, age, body mass index and serum 25 hydroxyvitamin D in postmenopausal women Clin Endocrinol 62 2005 738 741 (Pubitemid 40825945)
26. K.C. Baynes, B.J. Boucher, E.J. Feskens, and D. Kromhout Vitamin D glucose tolerance and insulinaemia in elderly men Diabetologia 40 1997 344 347 (Pubitemid 27096561)
27. J. Kositsawat, V.L. Freeman, B.S. Gerber, and S. Geraci Association of A1C levels with vitamin D status in US adults: data from the National Health and Nutrition Examination Survey Diabetes Care 33 2010 1236 1238
28. E. Liu, J.B. Meigs, A.G. Pittas, C.D. Economos, N.M. McKeown, and S.L. Booth Predicted 25-hydroxyvitamin D score and incident type 2 diabetes in the Framingham Offspring Study Am J Clin Nutr 91 2010 1627 1633
29. G. Grimnes, N. Emaus, R.M. Joakimsen, Y. Figenschau, T. Jenssen, and I. Njølstad Serum 25-hydroxyvitamin D and incident type 2 diabetes mellitus-eleven years follow-up from the Tromsø Study 1994-95 Diabetic Med 27 2010 1107 1115
30. A.G. Pittas, Q. Sun, J.E. Manson, B. Dawson-Hughes, and F.B. Hu Plasma 25-hydroxyvitamin D concentration and risk of incident type 2 diabetes in women Diabetes Care 33 2010 2021 2023
31. A.G. Pittas, B. Dawson-Hughes, T. Li, R.M. Van Dam, W.C. Willett, and J.E. Manson Vitamin D and calcium intake in relation to type 2 diabetes in women Diabetes Care 29 2006 650 656 (Pubitemid 44115368)
32. A.G. Pittas, and B. Dawson-Hughes Vitamin D and diabetes J Steroid Biochem Mol Biol. 121 2010 425 429
33. Monnier L, Colette C. Vitamin D and diabetes: Much ado about nothing? Diabetes Metab 2010; Aug 3. [Epub ahead of print].
34. R. Jorde, Y. Figenschau, N. Emaus, M. Hutchinson, and G. Grimnes Serum 25- hydroxyvitamin D levels are strongly related to systolic blood pressure but do not predict future hypertension Hypertension 55 2010 792 798
35. R. Scragg, M. Sowers, and C. Bell Serum 25-hydroxyvitamin D, ethnicity, and blood pressure in the Third National Health and Nutrition Examination Survey Am J Hypertens 20 2007 713 719 (Pubitemid 46936167)
36. R. Krause, M. Bühring, W. Hopfenmüller, M.F. Holick, and A.M. Sharma Ultraviolet B and blood pressure Lancet 352 1998 709 710 (Pubitemid 28398716)
37. Y.C. Li, J. Kong, M. Wei, Z.F. Chen, S.Q. Liu, and L.P. Cao 1, 25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system J Clin Invest 110 2002 229 238 (Pubitemid 34787360)
38. Vaidya A, Forman JP. Vitamin D and Hypertension. Current Evidence and Future Directions. Hypertension 2010 Oct 11. [Epub ahead of print].
39. Z. Ni, M. Smogorzewski, and S.G. Massry Effects of parathyroid hormone on cytosolic calcium of rat adipocytes Endocrinology 135 1994 1837 1844 (Pubitemid 24363874)
40. B. Xue, A.G. Greenberg, F.B. Kraemer, and M.B. Zemel Mechanism of intracellular calcium ([Ca2C]i) inhibition of lipolysis in human adipocytes FASEB J 15 2001 2527 2529
41. M.B. Zemel, H. Shi, B. Greer, D. Dirienzo, and P.C. Zemel Regulation of adiposity by dietary calcium FASEB J 14 2000 1132 1138 (Pubitemid 30350395)
42. R. Jorde, M. Sneve, N. Emaus, Y. Figenschau, and G. Grimnes Cross-sectional and longitudinal relation between serum 25-hydroxyvitamin D and body mass index. The Tromsø study Eur J Nutr 49 2010 401 407
43. E. Kamycheva, R. Joakimsen, and R. Jorde Intakes of calcium and vitamin D predict body mass index in the population of Northern Norway J Nutr 132 2002 102 106 (Pubitemid 36070586)
44. M. Sneve, Y. Figenschau, and R. Jorde Supplementation with cholecalciferol does not result in weight reduction in overweight and obese subjects Eur J Endocrinol 159 2008 675 684
45. A. Zittermann, S. Frisch, H.K. Berthold, C. Götting, J. Kuhn, and K. Kleesiek Vitamin D supplementation enhances the beneficial effects of weight loss on cardiovascular disease risk markers Am J Clin Nutr 89 2009 1321 1327
46. W.B. Kannel, W.P. Castelli, T. Gordon, and P.M. McNamara Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham study Ann Intern Med 74 1971 1 12
47. D.H. Kim, S. Sabour, U.N. Sagar, S. Adams, and D.J. Whellan Prevalence of hypovitaminosis D in cardiovascular diseases (from the National Health and Nutrition Examination Survey 2001 to 2004) Am J Cardiol 102 2008 1540 1544
48. Jorde R, Figenschau Y, Moira Hutchinson M, Emaus N, Grimnes G. High serum 25-hydroxyvitamin D concentrations are associated with a favourable serum lipid profile. Eur J Clin Nutr 2010 [Epub ahead of print].
49. E. Hyppönen, B.J. Boucher, D.J. Berry, and C. Power 25-hydroxyvitamin D, IGF-1, and metabolic syndrome at 45 years of age: a cross-sectional study in the 1958 British Birth Cohort Diabetes 57 2008 298 305
50. J. Kumar, P. Muntner, F.J. Kaskel, S.M. Hailpern, and M.L. Melamed Prevalence and associations of 25-hydroxyvitamin D deficiency in US children: NHANES 2001-2004 Pediatrics 124 2009 e362 370
51. Williams DM, Fraser A, Lawlor DA. Associations of vitamin D, parathyroid hormone and calcium with cardiovascular risk factors in US adolescents. Heart 2010 [Epub ahead of print].
52. J.P. Reis, D. von Mühlen, E.D. Michos, E.R. Miller 3rd, L.J. Appel, and M.R. Araneta Parathyroid hormone levels, and carotid atherosclerosis Atherosclerosis 207 2009 585 590
53. L. Lu, Z. Yu, A. Pan, F.B. Hu, O.H. Franco, and H. Li Plasma 25-hydroxyvitamin D concentration and metabolic syndrome among middle-aged and elderly Chinese individuals Diabetes Care 32 2009 1278 1283
54. D.M. Lee, M.K. Rutter, T.W. O'Neill, S. Boonen, D. Vanderschueren, and R. Bouillon European Male Ageing Study Group. Vitamin D, parathyroid hormone and the metabolic syndrome in middle-aged and older European men Eur J Endocrinol 161 2009 947 954
55. E.E. Delvin, M. Lambert, E. Levy, J. O'Loughlin, S. Mark, and K. Gray-Donald Vitamin D status is modestly associated with glycemia and indicators of lipid metabolism in French-Canadian children and adolescents J Nutr 140 2010 987 991
56. M.J. Bolland, C.J. Bacon, A.M. Horne, B.H. Mason, R.W. Ames, and T.K. Wang Vitamin D insufficiency and health outcomes over 5 y in older women Am J Clin Nutr 91 2010 82 89
57. V.C. Gaddipati, B.A. Bailey, R. Kuriacose, R.J. Copeland, T. Manning, and A.N. Peiris The relationship of vitamin d status to cardiovascular risk factors and amputation risk in veterans with peripheral arterial disease J Am Med Dir Assoc 12 2011 58 61
58. J. Hjelmesaeth, D. Hofsø, E.T. Aasheim, T. Jenssen, J. Moan, and H. Hager Parathyroid hormone, but not vitamin D, is associated with the metabolic syndrome in morbidly obese women and men: a cross-sectional study Cardiovasc Diabetol 8 2009 7
59. Karhapää P, Pihlajamäki J, Pörsti I, Kastarinen M, Mustonen J, Niemelä O, Kuusisto J. Diverse associations of 25-hydroxyvitamin D and 1,25-dihydroxy-vitamin D with dyslipidaemias. J Intern Med 2010 Aug 24. doi:10.1111/j.1365-2796.2010.02279.x. [Epub ahead of print].
60. E. Liu, J.B. Meigs, A.G. Pittas, N.M. McKeown, C.D. Economos, and S.L. Booth Plasma 25-hydroxyvitamin d is associated with markers of the insulin resistant phenotype in nondiabetic adults J Nutr 139 2009 329 334
61. J.P. Reis, D. von Mühlen, E.R. Miller 3rd, E.D. Michos, and L.J. Appel Vitamin D status and cardiometabolic risk factors in the United States adolescent population Pediatrics 124 2009 e371 379
62. S. Kayaniyil, R. Vieth, S.B. Harris, R. Retnakaran, J.A. Knight, and H.C. Gerstein Association of 25(OH)D and PTH with metabolic syndrome and its traditional and nontraditional components J Clin Endocrinol Metab 2011 168 175
63. T. Richart, L. Thijs, T. Nawrot, J. Yu, T. Kuznetsova, and E.J. Balkestein The metabolic syndrome and carotid intima-media thickness in relation to the parathyroid hormone to 25-OH-D(3) ratio in a general population Am J Hypertens 24 2011 102 109
64. N.G. Forouhi, J. Luan, A. Cooper, B.J. Boucher, and N.J. Wareham Baseline serum 25-hydroxy vitamin d is predictive of future glycemic status and insulin resistance. the Medical Research Council Ely Prospective Study 1990-2000 Diabetes 57 2008 2619 2625
65. R. Jorde, M. Sneve, P. Torjesen, and Y. Figenschau No improvement in cardiovascular risk factors in overweight and obese subjects after supplementation with vitamin D for 1 year J Intern Med 267 2010 462 472
66. S. Bansal, J.E. Buring, N. Rifai, S. Mora, F.M. Sacks, and P.M. Ridker Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women JAMA 298 2007 309 316 (Pubitemid 47080485)
67. N.E. Miller, D.S. Thelle, O.H. Forde, and O.D. Mjos The Tromsø heart-study. High-density lipoprotein and coronary heart-disease: a prospective case-control study Lancet 1 1977 965 968
68. M.L. Fernandez, and D. Densie Webb The LDL to HDL cholesterol ratio as a valuable tool to evaluate coronary heart disease risk J Am Coll Nutr 27 2008 1 5 (Pubitemid 351600516)
69. H. Dobnig, S. Pilz, H. Scharnagl, W. Renner, U. Seelhorst, and B. Wellnitz Independent association of low serum 25-hydroxyvitamin d and 1, 25-dihydroxyvitamin d concentrations with all-cause and cardiovascular mortality Arch Intern Med 168 2008 1340 1349 (Pubitemid 351930842)
70. R. Scragg, K.T. Khaw, and S. Murphy Effect of winter oral vitamin D3 supplementation on cardiovascular risk factors in elderly adults Eur J Clin Nutr 49 1995 640 646
71. A.M. Heikkinen, M.T. Tuppurainen, L. Niskanen, M. Komulainen, I. Penttilä, and S. Saarikoski Long-term vitamin D3 supplementation may have adverse effects on serum lipids during postmenopausal hormone replacement therapy Eur J Endocrinol 137 1997 495 502 (Pubitemid 27505309)
72. R. Andersen, C. Brot, H. Mejborn, C. Mølgaard, L.T. Skovgaard, and E. Trolle Vitamin D supplementation does not affect serum lipids and lipoproteins in Pakistani immigrants Eur J Clin Nutr 63 2009 1150 1153
73. M. Pfeifer, B. Begerow, H.W. Minne, D. Nachtigall, and C. Hansen Effects of a short-term vitamin D(3) and calcium supplementation on blood pressure and parathyroid hormone levels in elderly women J Clin Endocrinol Metab 86 2001 1633 1637 (Pubitemid 32377290)
74. P.R. von Hurst, W. Stonehouse, and J. Coad Vitamin D supplementation reduces insulin resistance in South Asian women living in New Zealand who are insulin resistant and vitamin D deficient - a randomised, placebo-controlled trial Br J Nutr 103 2010 549 555
75. J. Nagpal, J.N. Pande, and A. Bhartia A double-blind, randomized, placebo-controlled trial of the short-term effect of vitamin D3 supplementation on insulin sensitivity in apparently healthy, middle-aged, centrally obese men Diabet Med 26 2009 19 27
76. M.D. Witham, F.J. Dove, M. Dryburgh, J.A. Sugden, A.D. Morris, and A.D. Struthers The effect of different doses of vitamin D(3) on markers of vascular health in patients with type 2 diabetes: a randomised controlled trial Diabetologia 53 2010 2112 2119
77. Witham MD, Dove FJ, Sugden JA, Doney AS, Struthers AD. The effect of vitamin D replacement on markers of vascular health in stroke patients - A randomised controlled trial. Nutr Metab Cardiovasc Dis 2010 [Epub ahead of print].
78. S.N. Rajpathak, X. Xue, S. Wassertheil-Smoller, L. Van Horn, J.G. Robinson, and S. Liu Effect of 5 y of calcium plus vitamin D supplementation on change in circulating lipids: results from the Women's Health Initiative Am J Clin Nutr 91 2010 894 899
79. A. Iqbal, R. Jorde, and Y. Figenschau Serum lipid levels in relation to serum thyroid-stimulating hormone and the effect of thyroxine treatment on serum lipid levels in subjects with subclinical hypothyroidism: the Tromsø Study J Intern Med 260 2006 53 61 (Pubitemid 43894070)
80. K.E. Wong, F.L. Szeto, W. Zhang, H. Ye, J. Kong, and Z. Zhang Involvement of the vitamin D receptor in energy metabolism: regulation of uncoupling proteins Am J Physiol Endocrinol Metab 296 2009 E820 828
81. J.H. Wang, T. Keisala, T. Solakivi, A. Minasyan, A.V. Kalueff, and P. Tuohimaa Serum cholesterol and expression of ApoAI, LXRbeta and SREBP2 in vitamin D receptor knock-out mice J Steroid Biochem Mol Biol 113 2009 222 226
82. J.M. Blumberg, I. Tzameli, I. Astapova, F.S. Lam, J.S. Flier, and A.N. Hollenberg Complex role of the vitamin D receptor and its ligand in adipogenesis in 3T3-L1 cells J Biol Chem 281 2006 11205 11213 (Pubitemid 43855546)
83. J. Kong, and Y.C.M. Li Olecular mechanism of 1, 25-dihydroxyvitamin D3 inhibition of adipogenesis in 3T3-L1 cells Am J Physiol Endocrinol Metab 290 2006 E916 924
84. A. Dace, C. Martin-el Yazidi, J. Bonne, R. Planells, and J. Torresani Calcitriol is a positive effector of adipose differentiation in the OB 17 cell line: relationship with the adipogenic action of triiodothyronine Biochem Biophys Res Commun 232 1997 771 776 (Pubitemid 27214074)
85. H. Shi, A.W. Norman, W.H. Okamura, A. Sen, and M.B. Zemel 1alpha, 25-dihydroxyvitamin D3 inhibits uncoupling protein 2 expression in human adipocytes FASEB J 16 2002 1808 1810
86. N. Boon, G.B. Hul, J.H. Stegen, W.E. Sluijsmans, C. Valle, and D. Langin An intervention study of the effects of calcium intake on faecal fat excretion, energy metabolism and adipose tissue mRNA expression of lipid-metabolism related proteins Int J Obes 31 2007 1704 1712 (Pubitemid 350023157)
87. J.W. Welberg, J.F. Monkelbaan, E.G. de Vries, F.A. Muskiet, A. Cats, and E.T. Oremus Effects of supplemental dietary calcium on quantitative and qualitative fecal fat excretion in man Ann Nutr Metab 38 1994 185 191 (Pubitemid 24322234)
88. R. Christensen, J.K. Lorenzen, C.R. Svith, E.M. Bartels, E.L. Melanson, and W.H. Saris Effect of calcium from dairy and dietary supplements on faecal fat excretion: a meta-analysis of randomized controlled trials Obes Rev 10 2009 475 486
89. I.R. Reid, B. Mason, A. Horne, R. Ames, J. Clearwater, and U. Bava Effects of calcium supplementation on serum lipid concentrations in normal older women: a randomized controlled trial Am J Med 112 2002 343 347 (Pubitemid 34246263)
90. R. Jorde, J. Svartberg, and J. Sundsfjord Serum parathyroid hormone as a predictor of increase in systolic blood pressure in men J Hypertens 23 2005 1639 1644 (Pubitemid 41233422)
91. E. Kamycheva, J. Sundsfjord, and R. Jorde Serum parathyroid hormone level is associated with body mass index. The 5th Tromsø study Eur J Endocrinol 151 2004 167 172 (Pubitemid 39207010)
92. E. Kamycheva, J. Sundsfjord, and R. Jorde Serum parathyroid hormone levels predict coronary heart disease: the Tromsø Study Eur J Cardiovasc Prev Rehabil 11 2004 69 74 (Pubitemid 38388927)
93. E. Hagström, P. Hellman, T.E. Larsson, E. Ingelsson, L. Berglund, and J. Sundström Plasma parathyroid hormone and the risk of cardiovascular mortality in the community Circulation 119 2009 2765 2771
94. 2+ on the activation of microsomal triglyceride transfer protein in rat hepatocytes Biol Pharm Bull 28 2005 1418 1423
95. R. Vieth Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety Am J Clin Nutr 69 1999 842 856 Review (Pubitemid 29205056)
96. A. Zittermann, and R. Koerfer Protective and toxic effects of vitamin D on vascular calcification: clinical implications Mol Aspects Med 29 2008 423 432
97. P.E. Norman, and J.T. Powell Vitamin D, shedding light on the development of disease in peripheral arteries Arterioscler Thromb Vasc Biol 25 2005 39 46 (Pubitemid 40054252)
98. B.I. Freedman, L.E. Wagenknecht, K.G. Hairston, D.W. Bowden, J.J. Carr, and R.C. Hightower Vitamin D, adiposity, and calcified atherosclerotic plaque in african-americans J Clin Endocrinol Metab 95 2010 1076 1083
99. Razzaque MS. The dualistic role of vitamin D in vascular calcifications. Kidney Int 2010 Oct 20. [Epub ahead of print].
100. G. Bjelakovic, D. Nikolova, L.L. Gluud, R.G. Simonetti, and C. Gluud Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis JAMA 297 2007 842 857 (Pubitemid 46333949)
101. R. Clarke, J. Halsey, S. Lewington, E. Lonn, J. Armitage, and J.E. Manson B-Vitamin Treatment Trialists' Collaboration. Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause-specific mortality: meta-analysis of 8 randomized trials involving 37 485 individuals Arch Intern Med 170 2010 1622 1631
102. M. Ebbing, K.H. Bønaa, O. Nygrd, E. Arnesen, P.M. Ueland, and J.E. Nordrehaug Cancer incidence and mortality after treatment with folic acid and vitamin B12 JAMA 302 2009 2119 2126
103. K.M. Sanders, A.L. Stuart, E.J. Williamson, J.A. Simpson, M.A. Kotowicz, and D. Young Annual high-dose oral vitamin D and falls and fractures in older women: a randomized controlled trial JAMA 303 2010 1815 1822
104. A.C. Ross, J.E. Manson, S.A. Abrams, J.F. Aloia, P.M. Brannon, and S.K. Clinton The 2011 report on dietary reference intakes for calcium and vitamin d from the institute of medicine: what clinicians need to know J Clin Endocrinol Metab 96 2011 53 58
105. H.A. Bischoff-Ferrari, E. Giovannucci, W.C. Willett, T. Dietrich, and B. Dawson-Hughes Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes Am J ClinNutr 84 2006 18 28 (Pubitemid 44699167)